(Q34541484)

2 August 2017

A multi-institutional evaluation of active surveillance for low risk prostate cancer. (English)

1 reference

2 August 2017

1 reference

11

Larry Goldenberg

1 reference

2 August 2017

Scott E Eggener

1

1 reference

2 August 2017

Alex Mueller

2

1 reference

2 August 2017

Ryan K Berglund

3

1 reference

2 August 2017

Raj Ayyathurai

4

1 reference

2 August 2017

Cindy Soloway

5

1 reference

2 August 2017

Mark S Soloway

6

1 reference

2 August 2017

Robert Abouassaly

7

1 reference

2 August 2017

Eric A Klein

8

1 reference

2 August 2017

Steven J Jones

9

1 reference

2 August 2017

Chris Zappavigna

10

1 reference

2 August 2017

Peter T Scardino

12

1 reference

2 August 2017

James A Eastham

13

1 reference

2 August 2017

Bertrand Guillonneau

14

1 reference

2 August 2017

language of work or name

English

0 references

publication date

23 February 2009

1 reference

2 August 2017

1 reference

2 August 2017

181

1 reference

2 August 2017

4

1 reference

2 August 2017

1635-41; discussion 1641

1 reference

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Active surveillance for early-stage prostate cancer: review of the current literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

7 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Change in prostate cancer grade over time in men followed expectantly for stage T1c disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Contemporary trends in low risk prostate cancer: risk assessment and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Delayed versus immediate surgical intervention and prostate cancer outcome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Early outcomes of active surveillance for localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Natural History of Early, Localized Prostate Cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

Nomogram use for the prediction of indolent prostate cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237227

ACTIVE SURVEILLANCE WITH SELECTIVE DELAYED INTERVENTION: USING NATURAL HISTORY TO GUIDE TREATMENT IN GOOD RISK PROSTATE CANCER

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19233410

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19233410

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JURO.2008.11.109

1 reference

2 August 2017

1 reference

2 August 2017

1 reference